Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Nucala 100 mg/mL injection, 1 mL pen device |
has intended active ingredient |
True |
mepolizumab |
Inferred relationship |
Some |
1988660660 |
Nucala 100 mg/mL injection, 1 mL pen device |
has Australian BoSS |
True |
mepolizumab |
Inferred relationship |
Some |
1988660660 |
mepolizumab 100 mg/mL injection, pen device |
has intended active ingredient |
True |
mepolizumab |
Inferred relationship |
Some |
24922700 |
mepolizumab 100 mg/mL injection, pen device |
has Australian BoSS |
True |
mepolizumab |
Inferred relationship |
Some |
24922700 |
Nucala 100 mg/mL injection, 1 mL syringe |
has intended active ingredient |
True |
mepolizumab |
Inferred relationship |
Some |
811979188 |
Nucala 100 mg/mL injection, 1 mL syringe |
has Australian BoSS |
True |
mepolizumab |
Inferred relationship |
Some |
811979188 |
mepolizumab 100 mg/mL injection, syringe |
has intended active ingredient |
True |
mepolizumab |
Inferred relationship |
Some |
822361676 |
mepolizumab 100 mg/mL injection, syringe |
has Australian BoSS |
True |
mepolizumab |
Inferred relationship |
Some |
822361676 |
mepolizumab |
has intended active ingredient |
True |
mepolizumab |
Inferred relationship |
Some |
1 |
Nucala 100 mg powder for injection, 100 mg vial |
has intended active ingredient |
True |
mepolizumab |
Inferred relationship |
Some |
1073588594 |
Nucala 100 mg powder for injection, 100 mg vial |
has Australian BoSS |
True |
mepolizumab |
Inferred relationship |
Some |
1073588594 |
mepolizumab 100 mg injection, vial |
has intended active ingredient |
True |
mepolizumab |
Inferred relationship |
Some |
233247854 |
mepolizumab 100 mg injection, vial |
has Australian BoSS |
True |
mepolizumab |
Inferred relationship |
Some |
233247854 |